CT-2103 vs Gemcitabine or Vinorelbine for the Treatment of PS [performance status] = 2 Patients With Chemotherapy Naive Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase III Study
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Paclitaxel poliglumex (Primary) ; Gemcitabine; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms STELLAR-4
- Sponsors CTI BioPharma
- 02 Oct 2020 Status changed from active, no longer recruiting to discontinued.
- 07 Jul 2008 Results reported in the Journal of Thoracic Oncology in July 2008, according to a Cell Therapeutics media release.
- 01 Jul 2008 Primary endpoint results published in the Journal of Thoracic Oncology in July 2008